Hajim School of Engineering and Applied Sciences UofR logo BME SMD logo Hajim SEAS logo

Tuesday, Jan 17, 2012

9:00 AM10:00 AM MC 3-6408 (K-307)

Upcoming Events

There are no upcoming events to display

Past events

Special BME Department Seminar: Kurt Schilling, Ph.D.

Leading Edge Trends in Medical Devices and Diagnostics: Innovation at Johnson and Johnson Ortho Clinical Diagnostics

Johnson & Johnson Ortho Clinical Diagnostics

Abstract

Ortho Clinical Diagnostics is a company in Johnson and Johnson's Medical Devices and Diagnostics division. OCD develops, manufactures, sells and supports diagnostic instruments and assays for:

  • Clinical Chemistry & Immunodiagnostics across many diseases and conditions
  • Transfusion Medicine, including donor screening and immuno-hematology
  • Companion Diagnostics to assist professionals and patients in selecting and/or predicting the safety and efficacy of drugs, surgeries and other medical treatments

In addition to our diagnostics products, OCD also produces extracorporeal photophoresis technology to treat diseases such as certain lymphomas and graft versus host disease. To support these businesses, we must generate sophisticated instruments with advanced hardware, software and automation technology. Furthermore, we must develop proprietary reagents, precisely coated surfaces and matrices, and robust new assays to meet regulatory requirements and to satisfy the diagnostic needs and evolving menus of our customers in hospital labs, reference labs, blood centers, and various decentralized points of care. Going forward, OCD must continue to deliver highly innovative technologies in order to respond to a number of technical and marketplace trends that are impacting our business. These include, but are not limited to, the emergence of personalized medicine, decentralized, point of care diagnostics, and preventative health and wellness; all are required for more cost effective, accessible and efficacious healthcare solutions.

This presentation will touch on some of the near and mid-term technologies driving our current and future platforms and that overlap with interests of investigators at the U of R. We will also discuss careers paths in innovation at OCD specifically, and Johnson and Johnson more broadly, and the training and preparation typically required.